Asset Details
Do you wish to reserve the book?
Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation
Do you wish to request the book?
Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation
2017
Overview
Objective： Cancer cell radioresistance is a stumbling block in radiation therapy. The activity in the nuclear factor kappa B （NFκ B） pathway correlates with anti-apoptotic mechanisms and increased radioresistance. The IKK complex plays a major role in NFκB activation upon numerous signals. In this study, we examined the interaction between ionizing radiation （IR） and different members of the IKK-NFκB pathway, as well as upstream activators, RAF1, ERK, and AKT1. Methods： The effect of 4 Gy of IR on the expression of the RAF1-ERK-IKK-NFκB pathway was examined in A549 and H1299 lung cancer cell lines using Western blot analysis and confocal microscopy. We examined changes in radiation sensitivity using gene silencing or pharmacological inhibitors of ERK and IKKβ. Results： IKKα, IKKγ, and IκBα increased upon exposure to IR, thereby affecting nuclear levels of NFκB （phospho-p65）. ERK inhibition or siRNA-mediated down-regulation of RAF1 suppressed the post-irradiation survival of the examined lung cancer cell lines. A similar effect was detected on survival upon silencing IKKα/IKKγ or inhibiting IKKβ. Conclusions： Exposure of lung cancer cells to IR results in NFκ B activation via IKK. The genetic or pharmacological blockage of the RAF 1-ERK-IKK-NFκB pathway sensitizes cells to therapeutic doses of radiation. Therefore, the IKK pathway is a promising target for therapeutic intervention in combination with radiotherapy.
Publisher
Department of Radiotherapy/Oncology, Democritus University of Thrace and University General Hospital of Alexandroupolis, Alexandroupolis 68100, Greece%Department of Pathology, Democritus University of Thrace and University General Hospital of Alexandroupolis, Alexandroupolis 68100, Greece,Chinese Anti-Cancer Association,China Anti-Cancer Association
Subject
